Metropolitan Life Insurance Company (MetLife)’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,502
Closed -$136K 2394
2022
Q3
$136K Hold
6,502
0.01% 852
2022
Q2
$135K Hold
6,502
0.01% 899
2022
Q1
$109K Sell
6,502
-19,344
-75% -$338K ﹤0.01% 1141
2021
Q4
$516K Hold
25,846
0.01% 1396
2021
Q3
$469K Sell
25,846
-2,310
-8% -$53K 0.01% 1508
2021
Q2
$760K Sell
28,156
-3,057
-10% -$85.5K 0.01% 1221
2021
Q1
$935K Sell
31,213
-1,216
-4% -$41.5K 0.01% 984
2020
Q4
$932K Buy
32,429
+3,056
+10% +$82.5K 0.01% 921
2020
Q3
$717K Sell
29,373
-600
-2% -$12.9K 0.01% 949
2020
Q2
$536K Buy
29,973
+27,623
+1,175% +$363K 0.01% 1150
2020
Q1
$19.1K Buy
2,350
+1
+0% +$11 ﹤0.01% 2445
2019
Q4
$31K Sell
2,349
-24,824
-91% -$301K ﹤0.01% 2508
2019
Q3
$323K Buy
27,173
+126
+0.5% +$2.33K 0.01% 1561
2019
Q2
$662K Buy
27,047
+105
+0.4% +$3.02K 0.01% 1127
2019
Q1
$858K Buy
+26,942
New +$956K 0.02% 960

Other funds holding CVET

Metropolitan Life Insurance Company (MetLife)'s CVET Position: Q4 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 6,502 shares — an estimated $136K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $935K in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,502 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $136K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Covetrus, Inc. Common Stock position peaked at $935K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.